Forecast

The analysts' average price target is +26,30€ (+4.957,69%). The median is +25,75€ (+4.851,92%).

Buy	8
Hold	0
Sell	0

News Go to news feed

Electrovaya delivers first battery modules to Japan and secures new large orders

Electrovaya completed its first shipment of 1.5‑kWh battery modules from Canada to Japan for a global construction equipment manufacturer and received UN38.3 certification from TÜV SÜD. The company expects additional sales through a partnership with Sumitomo Corporation Power and Mobility, received new orders from Fortune‑100 customers and signed supply agreements including with Janus Electric. Electrovaya is also planning cell manufacturing in Jamestown, New York, and has achieved UL2580 certifications for upcoming models. » More on de.investing.com
Janus International reports resignation from board and replacement of audit committee chair

The Janus International Group announced the immediate resignation of Thomas A. Szlosek from the board of directors and as chair of the audit committee; Heather Harding was named the new chair effective immediately. The company emphasized the resignation was not due to disagreements over operating matters. Janus International also topped expectations in the second quarter of 2025 with $0.20 earnings per share and $228.1 million in revenue, after which KeyBanc and Jefferies raised their price targets. » More on de.investing.com
Janus International beats expectations with strong quarterly results and share buyback program

Janus International Group significantly exceeded earnings expectations in the second quarter of 2025, reporting earnings per share of $0.20 and revenue of $228.1 million, both above forecasts. The stock rose 14.8% in pre-market trading, and the company announced a $75 million share buyback program. Despite a year-over-year decline in revenue and EBITDA, the company remains optimistic for the full year and expects margin improvement. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, JanOne has already paid 0,14€ in dividends. The last payout was in June.

Financials

In the last quarter, JanOne had revenue of 189.66m€ and net profit of 9.40m€

(EUR)	Jun 2026	YoY
Revenue	+189.66m	-
Gross profit	+46.78m	-
Net profit	+9.40m	-
EBITDA	+60.71m	-

Fundamentals

Metric	Value
Market capitalization	+5.71b€
Number of shares	212.22m
52-week high/low	+28,18€ - +19,54€
Dividend yield	+27,63%
Dividends TTM	+0,14€
Beta	0,32
P/E ratio	+7.290,70
PEG ratio	+72,91
P/B ratio	+2,23
P/S ratio	+15,96

Company profile

JanOne Inc. ist ein biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Identifizierung, den Erwerb, die Lizenzierung, die Entwicklung, die Partnerschaft und die Vermarktung neuartiger, nicht-opioider und nicht-süchtig machender Therapien konzentriert, um den ungedeckten medizinischen Bedarf für die Behandlung von Schmerzen und Sucht zu decken. Das Unternehmen ist in drei Segmenten tätig: Biotechnologie, Recycling und Technologie. Der führende Produktkandidat des Unternehmens ist JAN101, ein patentiertes pharmazeutisches Präparat mit Natriumnitrit zur oralen und anhaltenden Freisetzung, das auf eine schlechte Durchblutung der Extremitäten bei Patienten mit Diabetes oder peripherer Arterienerkrankung abzielt, um Schmerzen zu behandeln. Darüber hinaus bietet das Unternehmen schlüsselfertige Geräte-Recycling- und Austauschdienste für Versorgungsunternehmen und andere Sponsoren von Energieeffizienzprogrammen an und entwirft, entwickelt und verkauft Mobilfunk-Sende-/Empfangsmodule und damit verbundene drahtlose Dienste. Das Unternehmen war früher unter dem Namen Appliance Recycling Centers of America, Inc. bekannt und änderte im September 2019 seinen Namen in JanOne Inc. JanOne Inc. wurde 1976 gegründet und hat seinen Hauptsitz in Las Vegas, Nevada.